Top Markets
#1 Derive Derive +30.44%
#2 Audiera Audiera +15.71%
#3 Cross Cross +15.35%
#4 Geodnet Geodnet +14.67%
#5 Humanity Humanity +11.95%
#6 Biconomy Biconomy +10.67%
#7 The Bitcoin Bull The Bitcoin Bull +9.78%
#8 Cap Cap +9.36%
#9 Based Based +8.40%
#10 Quack AI Quack AI +7.88%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Clasificación en acciones #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Precio por acción
$1.84
Última sincronización: 2026-08-11
Capitalización bursátil
$3.51M
Cambio (1 día)
0.46%
Cambio (1 año)
-62.71%
País
US
Comercio Dogwood Therapeutics, Inc. (DWTX)

Categoría

Healthcare
Historial del precio de la acción de Dogwood Therapeutics, Inc. (DWTX)
Precio más alto de cierre: $1.81 el 2026-08-01

Precio más bajo de cierre: $241.05 el 2020-12-01
Historial del precio de la acción de Dogwood Therapeutics, Inc. desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -37.58%
2025 122.27%
2024 -84.09%
2023 144.93%
2022 -94.85%
2021 -47.68%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE